ME
MEDP
Medpace Holdings, Inc.
$467.34
-1.63%
$13.3B
No data for this timeframe.
Vol
Market Cap$13.3B
Cap SizeLarge Cap
Analyst ConsensusHold (45%)
Inst. Holders50 funds
Inst. Value$6.6B
Inst. Activity28 buys / 22 sells
Insider Activity0B / 2S
Insider Net $-$21.8M
SEC Reports3
Congressional4 trades
Exchange Nasdaq·Sector Services-Commercial Physical & Biological Research·Inc. DE·CIK 0001668397·Prev Close $475.07
Recent Activity
Jun 8, 2026
SEC
Medpace, Inc. obtained a default judgment against Agenus Inc. and Garo H. Armen in a breach-of-contract and breach-of-fi
COURT-RULING — Impact 5/10
May 28, 2026
Insider
EWALD STEPHEN P acquired via exercise 16,349 shares
General Counsel & Corp. Secy. @ $138.87 ($2.3M)
May 28, 2026
Insider
EWALD STEPHEN P sold 16,349 shares
General Counsel & Corp. Secy. @ $450.00 ($7.4M)
May 18, 2026
dark_pool
Dark Pool: MEDP — 0.6M shares, 27,512 trades
Week starting 2026-05-18. Total ATS volume: 553,061 shares across 27,512 trades.
May 15, 2026
Insider
Carley Brian T was granted 1,110 shares
Director
May 15, 2026
Congress
David Taylor buy
$1,001 - $15,000 — House
Apr 22, 2026
SEC
Medpace reported strong Q1 2026 earnings with revenue up 26.5% YoY and EPS of $4.28, beating consensus. However, Preside
8-K — Impact 6/10
Apr 1, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Price Targets
$442.83
-5.2% upside
Sell
Current $467.34
Low $329.00
Median $456.00
High $495.00
12 analysts
$329.00
$495.00
Analyst Ratings
4Strong Buy
5Buy
10Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 24, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Apr 24, 2026 | BMO Capital | MAINTAIN | Market Perform → Market Perform |
| Apr 24, 2026 | RBC Capital | MAINTAIN | Outperform → Outperform |
| Apr 24, 2026 | Baird | MAINTAIN | Outperform → Outperform |
| Mar 6, 2026 | Barclays | UPGRADE | Underweight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $3.96 ▼ -3.0% | $3.71 — $4.11 | 28% YoY | 8 |
| Next Q | $4.26 ▼ -5.2% | $4.06 — $4.43 | 10% YoY | 8 |
| Current FY | $17.06 | $16.70 — $17.78 | 12% YoY | 10 |
| Next FY | $18.56 | $17.85 — $19.26 | 9% YoY | 10 |
Latest Reports
BULLISH
COURT-RULING
5/10
Medpace, Inc. obtained a default judgment against Agenus Inc. and Garo H. Armen in a breach-of-contract and breach-of-fi
Jun 8, 2026
MIXED
8-K
6/10
Medpace reported strong Q1 2026 earnings with revenue up 26.5% YoY and EPS of $4.28, beating consensus. However, Preside
Apr 22, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $1.2B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $538.6M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $485.5M | — |
| WASATCH ADVISORS LP | $371.6M | — |
| STATE STREET CORP | $327.6M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | EWALD STEPHEN | M | $2.3M |
| May 28, 2026 | EWALD STEPHEN | SELL | $7.4M |
| May 15, 2026 | Carley Brian | A | $0.00 |
| May 15, 2026 | DAVENPORT FRED | A | $0.00 |
| May 15, 2026 | Gwadry-Sridhar Femida | A | $0.00 |
Congressional Trades
2 members: 3 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| David Taylor | R | BUY | $1,001 - $15,000 |
| David Taylor | R | BUY | $1,001 - $15,000 |
| David Taylor | R | BUY | $1,001 - $15,000 |
50 institutional holders with $6.6B total value (13,791,311 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 28 institutions added/increased vs 22 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2,470,440 | $1.2B | 17.9% | — |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1,121,689 | $538.6M | 8.1% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1,011,071 | $485.5M | 7.3% | — |
| 4 | WASATCH ADVISORS LP | 773,931 | $371.6M | 5.6% | — |
| 5 | STATE STREET CORP | 682,229 | $327.6M | 5.0% | — |
| 6 | Invesco Ltd. | 577,574 | $277.3M | 4.2% | — |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 504,668 | $242.3M | 3.7% | — |
| 8 | BAILLIE GIFFORD & CO | 503,191 | $241.6M | 3.7% | — |
| 9 | Mawer Investment Management Ltd. | 446,104 | $214.2M | 3.2% | — |
| 10 | D. E. Shaw & Co., Inc. | 432,602 | $207.7M | 3.1% | — |
| 11 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 395,769 | $190.0M | 2.9% | — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 348,485 | $167.3M | 2.5% | — |
| 13 | MORGAN STANLEY | 288,422 | $138.5M | 2.1% | TRIM -30.8% |
| 14 | BANK OF AMERICA CORP /DE/ | 212,183 | $101.9M | 1.5% | — |
| 15 | FRANKLIN RESOURCES INC | 201,711 | $96.9M | 1.5% | TRIM -32.6% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 196,513 | $94.4M | 1.4% | — |
| 17 | TWO SIGMA INVESTMENTS, LP | 176,557 | $84.8M | 1.3% | — |
| 18 | Clearbridge Investments, LLC | 175,966 | $84.5M | 1.3% | — |
| 19 | GOLDMAN SACHS GROUP INC | 168,487 | $80.9M | 1.2% | — |
| 20 | FMR LLC | 160,585 | $77.1M | 1.2% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 416,678 | 288,422 | -30.8% | $138.5M | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 299,472 | 201,711 | -32.6% | $96.9M | 2026-Q1 |
| Epoch Investment Partners, Inc. | DOUBLED | 28,958 | 140,959 | +386.8% | $67.7M | 2026-Q1 |
| TD ASSET MANAGEMENT INC | DOUBLED | 51,540 | 133,053 | +158.2% | $63.9M | 2026-Q1 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | ADD | 80,218 | 130,249 | +62.4% | $62.5M | 2026-Q1 |
| Assenagon Asset Management S.A. | DOUBLED | 7,272 | 116,323 | +1499.6% | $55.9M | 2026-Q1 |
| NORDEA INVESTMENT MANAGEMENT AB | ADD | 63,784 | 113,462 | +77.9% | $52.8M | 2026-Q1 |
| MAIRS & POWER INC | ADD | 66,665 | 85,720 | +28.6% | $41.2M | 2026-Q1 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | TRIM | 139,361 | 74,730 | -46.4% | $35.9M | 2026-Q1 |
| Amundi | DOUBLED | 3,851 | 61,139 | +1487.6% | $29.4M | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 89,282 | 55,421 | -37.9% | $26.6M | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | DOUBLED | 21,180 | 54,594 | +157.8% | $26.2M | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | TRIM | 89,741 | 45,686 | -49.1% | $21.9M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | NEW | — | 42,293 | — | $20.3M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | ADD | 25,041 | 32,450 | +29.6% | $15.6M | 2026-Q1 |
| Allianz Asset Management GmbH | DOUBLED | 14,207 | 29,837 | +110.0% | $14.3M | 2026-Q1 |
| FEDERATED HERMES, INC. | DOUBLED | 12,027 | 29,262 | +143.3% | $14.1M | 2026-Q1 |
| LAZARD ASSET MANAGEMENT LLC | ADD | 20,038 | 25,640 | +28.0% | $12.3M | 2026-Q1 |
| Gotham Asset Management, LLC | ADD | 17,242 | 25,474 | +47.7% | $12.2M | 2026-Q1 |
| Artemis Investment Management LLP | NEW | — | 24,010 | — | $11.5M | 2026-Q1 |
| Swedbank AB | TRIM | 22,000 | 12,000 | -45.5% | $5.8M | 2026-Q1 |
| PFA Pension, Forsikringsaktieselskab | DOUBLED | 3,323 | 11,589 | +248.8% | $5.6M | 2026-Q1 |
| DEUTSCHE BANK AG\ | ADD | 6,948 | 9,915 | +42.7% | $4.8M | 2026-Q1 |
| MARSHALL WACE, LLP | NEAR_EXIT | 44,951 | 9,853 | -78.1% | $4.7M | 2026-Q1 |
| PRUDENTIAL PLC | TRIM | 14,360 | 9,729 | -32.2% | $4.7M | 2026-Q1 |
11 unique insiders with 26 transactions. Net insider value: -$21.8M ($0.00 bought, $21.8M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | EWALD STEPHEN P | General Counsel & Corp. Secy. | EXERCISE | 16,349 | $138.87 | $2.3M |
| May 28, 2026 | EWALD STEPHEN P | General Counsel & Corp. Secy. | SELL | 16,349 | $450.00 | $7.4M |
| May 15, 2026 | Carley Brian T | Director | AWARD | 1,110 | — | — |
| May 15, 2026 | DAVENPORT FRED B JR | Director | AWARD | 1,110 | — | — |
| May 15, 2026 | Gwadry-Sridhar Femida H. | Director | AWARD | 1,110 | — | — |
| May 15, 2026 | Kraft Robert O. | Director | AWARD | 1,110 | — | — |
| May 15, 2026 | McCarthy Cornelius P. III | Director | AWARD | 1,110 | — | — |
| May 15, 2026 | Zander Dani S. | Director | AWARD | 1,110 | — | — |
| Apr 24, 2026 | Brady Kevin M. | CFO & Treasurer | EXERCISE | 7,000 | $138.87 | $972.1K |
| Apr 24, 2026 | Brady Kevin M. | CFO & Treasurer | AWARD | 10,000 | — | — |
| Apr 24, 2026 | Brady Kevin M. | CFO & Treasurer | AWARD | 5,000 | — | — |
| Apr 24, 2026 | BURWIG SUSAN E | Exec. VP, Operations | AWARD | 10,000 | — | — |
| Apr 24, 2026 | BURWIG SUSAN E | Exec. VP, Operations | AWARD | 5,000 | — | — |
| Apr 24, 2026 | EWALD STEPHEN P | General Counsel & Corp. Secy. | EXERCISE | 3,500 | $138.87 | $486.0K |
| Apr 24, 2026 | EWALD STEPHEN P | General Counsel & Corp. Secy. | AWARD | 10,000 | — | — |
| Apr 24, 2026 | EWALD STEPHEN P | General Counsel & Corp. Secy. | AWARD | 5,000 | — | — |
| Apr 24, 2026 | Troendle August J. | CEO | AWARD | 20,000 | — | — |
| Apr 24, 2026 | Troendle August J. | CEO | AWARD | 10,000 | — | — |
| Mar 31, 2026 | Carley Brian T | Director | EXERCISE | 36 | — | — |
| Mar 31, 2026 | Kraft Robert O. | Director | EXERCISE | 33 | — | — |
| Mar 31, 2026 | McCarthy Cornelius P. III | Director | EXERCISE | 29 | — | — |
| Mar 18, 2026 | BURWIG SUSAN E | Exec. VP, Operations | EXERCISE | 12,000 | $166.73 | $2.0M |
| Mar 17, 2026 | GEIGER JESSE J | President | SELL | 31,707 | $455.30 | $14.4M |
| Mar 17, 2026 | GEIGER JESSE J | President | EXERCISE | 31,707 | $138.87 | $4.4M |
| Feb 13, 2026 | Carley Brian T | Director | EXERCISE | 6,472 | $54.99 | $355.9K |
| Feb 13, 2026 | BURWIG SUSAN E | Exec. VP, Operations | EXERCISE | 10,984 | $107.93 | $1.2M |
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 4.7/10.
BULLISH
COURT-RULING
5/10
Medpace, Inc. obtained a default judgment against Agenus Inc. and Garo H. Armen in a breach-of-contr
Jun 8, 2026
MIXED
8-K
6/10
Medpace reported strong Q1 2026 earnings with revenue up 26.5% YoY and EPS of $4.28, beating consens
Apr 22, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (45% buy). Based on 20 analysts: 4 strong buy, 5 buy, 10 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$442.83 mean target
-5.2% upside
Sell (2.62)
$329.00 Low
$495.00 High
| Metric | Value |
|---|---|
| Current Price | $467.34 |
| Target Low | $329.00 |
| Target Mean | $442.83 |
| Target Median | $456.00 |
| Target High | $495.00 |
| # Analysts | 12 |
| Recommendation | Sell (2.62) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$3.96 | $3.71 | $4.11 | 27.8% | -3.0% | 3↑ 5↓ | $0.7B | 14.4% | 8 |
| Next Q 2026-09-30 |
$4.26 | $4.06 | $4.43 | 10.3% | -5.2% | 0↑ 8↓ | $0.7B | 4.0% | 8 |
| Current FY 2026-12-31 |
$17.06 | $16.70 | $17.78 | 11.7% | +0.0% | 4↑ 6↓ | $2.8B | 9.5% | 10 |
| Next FY 2027-12-31 |
$18.56 | $17.85 | $19.26 | 8.8% | +0.0% | 3↑ 7↓ | $2.9B | 4.7% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $3.963 | |
| 7d ago | $4.090 | -0.127 |
| 30d ago | $4.085 | -0.122 |
| 60d ago | $4.083 | -0.120 |
| 90d ago | $3.840 | +0.123 |
8 analyst firms have rated this stock: 3 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 24, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 24, 2026 | BMO Capital | MAINTAIN | Market Perform | Market Perform |
| Apr 24, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Apr 24, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Mar 6, 2026 | Barclays | UPGRADE | Underweight | Equal-Weight |
| Mar 3, 2026 | RBC Capital | INITIATE | — | Outperform |
| Feb 18, 2026 | TD Cowen | UPGRADE | Sell | Hold |
| Feb 13, 2026 | Jefferies | UPGRADE | Hold | Buy |
| Feb 11, 2026 | Barclays | MAINTAIN | Underweight | Underweight |
| Feb 11, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
| Feb 11, 2026 | Leerink Partners | MAINTAIN | Market Perform | Market Perform |
| Dec 15, 2025 | Barclays | MAINTAIN | Underweight | Underweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| May 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| Apr 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| Mar 1, 2026 | 4 | 4 | 9 | 2 | 0 | 42% | |
| Feb 1, 2026 | 0 | 1 | 11 | 4 | 2 | 6% | |
| Jan 1, 2026 | 0 | 1 | 11 | 4 | 2 | 6% |
Strong BuyBuyHoldSellStrong Sell
2 members of Congress traded this stock: 3 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | May 29, 2026 (15d) |
| May 15, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | May 29, 2026 (15d) |
| Feb 26, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | Mar 9, 2026 (12d) |
| Jan 15, 2026 | Gilbert Cisneros | D | HOUSE | SELL | $15,001 - $50,000 | Medpace Holdings Inc | Feb 16, 2026 (33d) |
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 13, 2026
Clinical Trial
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Phase Phase 3 — COMPLETED
May 23, 2026
Clinical Trial
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Phase Phase 3 — COMPLETED
May 18, 2026
dark_pool
Dark Pool: MEDP — 0.6M shares, 27,512 trades
Week starting 2026-05-18. Total ATS volume: 553,061 shares across 27,512 trades.
May 11, 2026
dark_pool
Dark Pool: MEDP — 0.5M shares, 25,163 trades
Week starting 2026-05-11. Total ATS volume: 544,733 shares across 25,163 trades.
May 4, 2026
dark_pool
Dark Pool: MEDP — 0.5M shares, 28,032 trades
Week starting 2026-05-04. Total ATS volume: 549,783 shares across 28,032 trades.
Apr 29, 2026
short_interest
FTD: MEDP — 2,466 shares ($1.0M) failed to deliver
Settlement: 20260429, Price: $409.65, FTD Value: $1,010,196.9, MEDPACE HLDGS INC COM
Apr 27, 2026
dark_pool
Dark Pool: MEDP — 0.7M shares, 29,451 trades
Week starting 2026-04-27. Total ATS volume: 688,446 shares across 29,451 trades.
Apr 23, 2026
short_volume
Short Volume: MEDP — 72.0% short (0.5M / 0.7M)
Short: 530,634 | Exempt: 18,176 | TRF Vol: 736,516 | Short Ratio: 72.0% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
earnings_calendar
MEDP Q1 2026 Earnings After Market Close — 2026-04-22
Apr 20, 2026
dark_pool
Dark Pool: MEDP — 1.2M shares, 35,386 trades
Week starting 2026-04-20. Total ATS volume: 1,204,732 shares across 35,386 trades.
Apr 13, 2026
dark_pool
Dark Pool: MEDP — 0.7M shares, 25,219 trades
Week starting 2026-04-13. Total ATS volume: 699,606 shares across 25,219 trades.
Apr 6, 2026
dark_pool
Dark Pool: MEDP — 0.5M shares, 21,210 trades
Week starting 2026-04-06. Total ATS volume: 469,290 shares across 21,210 trades.
Mar 30, 2026
dark_pool
Dark Pool: MEDP — 0.2M shares, 14,534 trades
Week starting 2026-03-30. Total ATS volume: 241,220 shares across 14,534 trades.
Mar 23, 2026
dark_pool
Dark Pool: MEDP — 0.4M shares, 17,978 trades
Week starting 2026-03-23. Total ATS volume: 388,542 shares across 17,978 trades.
Mar 16, 2026
dark_pool
Dark Pool: MEDP — 0.4M shares, 19,823 trades
Week starting 2026-03-16. Total ATS volume: 398,651 shares across 19,823 trades.
Mar 9, 2026
dark_pool
Dark Pool: MEDP — 0.5M shares, 24,264 trades
Week starting 2026-03-09. Total ATS volume: 516,510 shares across 24,264 trades.
Mar 2, 2026
dark_pool
Dark Pool: MEDP — 0.5M shares, 22,654 trades
Week starting 2026-03-02. Total ATS volume: 479,187 shares across 22,654 trades.
Dec 4, 2025
Enforcement
Medpace, Inc. v. Agenus Inc. et al.
Court ruling from District Court, S.D. New York. Docket: 1:25-cv-04179